Back to 
RTW Investments, LP
RTW Investments, LP
CLDX
Showing 0 of 16 quarters
Position history for RTW Investments, LP's holdings in Celldex Therapeutics, Inc.
No. RTW Investments exited its CLDX (Celldex Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 3,463,201 shares worth $137.4M. RTW Investments first reported CLDX in Q2 2020 and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.